2022 Bioactive Materials Lifetime Achievement Award Winner: Prof. Guillermo A. Ameer
Published 11 May, 2022
Bioactive Materials Lifetime Achievement Award, an award from the journal Bioactive Materials (IF 2020: 14.593; Ranking 1st in the materials science, biomaterials category; http://www.keaipublishing.com/en/journals/bioactive-materials/). The annual Bioactive Materials Lifetime Achievement Award was established in 2021 to recognize excellence in research and development in the field. It is presented to the person judged to have demonstrated excellence and leadership in bioactive materials, including basic science and translation to practice. Each year the general bioactive materials community is invited to nominate suitable award candidates who should be world leaders in the field of bioactive materials, whose accomplishments in discovery and translation to practice are unsurpassed. All candidates are placed on a ballot, which is then considered by the selection committee. The candidate with the most points was chosen as the Lifetime Achievement Award winner. In 2022, the winner is Prof. Guillermo A. Ameer from Northwestern University, Evanston, IL, United States.
Biosketch of the winner:
Dr. Guillermo Ameer, ScD
Dr. Ameer is the Daniel Hale Williams professor of Biomedical Engineering and Surgery in the Biomedical Engineering Department at the McCormick School of Engineering and the Department of Surgery at the Feinberg School of Medicine, Northwestern University. He is the founding director of the Center for Advanced Regenerative Engineering (CARE). His research interests include regenerative engineering, biomaterials, additive manufacturing for biomedical devices, controlled drug delivery and bio/nanotechnology for therapeutics and diagnostics. Dr. Ameer’s laboratory pioneered the development and tissue regeneration applications of citrate-based biomaterials (CBB), the core technology behind the innovative bioresorbable orthopaedic tissue fixation devices CITREFIXTM, CITRESPLINETM, and CITRELOCKTM, which were recently cleared by the F.D.A for clinical use and marketed worldwide by Stryker Corporation. CBBs are the first thermoset synthetic polymers used for implantable biodegradable medical devices. Co-founder of several companies, Dr. Ameer has over 300 publications and conference abstracts and 60 patents in 9 countries. His awards include the Key to the City of Panama, the Society for Biomaterials Clemson Award for Contributions to the Literature and the Technology Innovation and Development Award. Dr. Ameer is a Fellow of the National Academy of Inventors and a member of the National Academy of Medicine. He is a Deputy Editor for the AAAS journal Science Advances and Associate Editor for the Regenerative Engineering and Translational Medicine journal. Dr. Ameer is a member of the board of directors of the Regenerative Engineering Society and Chair of the College of Fellows of the American Institute of Medical and Biological Engineering.
